Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 6Terminated 4Recruiting 3Unknown 2Withdrawn 1Active not recruiting 1

Sponsor Class

INDIV 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Gastrointestinal 1

Conditions

Neoplasms 1Barrett Esophagus 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 290Drug Therapy 276Bevacizumab 248apatinib 247camrelizumab 219Etoposide 201Irinotecan 182Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Proflavine × Clear all
NCT02018367 2021-01-14

Accuracy, Yield and Clinical Impact of a Low-Cost HRME in the Early Diagnosis of Esophageal Adenocarcinoma

Anandasabapathy, Sharmila, M.D.

Phase 2 Unknown
100 enrolled
Gastrointestinal

Barrett Esophagus

NCT02029937 2021-01-14

High Resolution Microendoscopy for the Detection of Esophageal Squamous Cell Neoplasia

Anandasabapathy, Sharmila, M.D.

Phase 2 Unknown
1,300 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡